Scinai Immunotherapeutics Ltd. issued a press release on June 10, 2026, detailing its first quarter 2026 financial results. The update highlighted the expansion of its Contract Development and Manufacturing Organization (CDMO) platform and progress regarding strategic growth initiatives. The company is a biotechnology firm focused on immunotherapy development and manufacturing services.
